Home › Funds › PFM Health Sciences, LP › ROIV

PFM Health Sciences, LP position in ROIV

ROIVANT SCIENCES LTD · Health Care

PFM Health Sciences, LP reported holding 268,008 shares of ROIV (ROIVANT SCIENCES LTD) in its Q2 2026 13F filing — a position valued at US$9.5M, representing 0.83% of its reported portfolio and ranking #46 among its reported holdings. PFM Health Sciences, LP has disclosed ROIV holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)268.01K sh
Reported value held$9.48M
Portfolio Weight0.83%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's ROIV position evolved

PFM Health Sciences, LP first disclosed a stake in ROIV in Q3 2023 at 1,215,033 shares (US$14.2M). Across 4 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 268,008 shares valued at US$9.5M — an increase of 60,562 shares quarter over quarter.. Notable position changes include a 29% increase in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.22M $14.19M New
Q4 2023 1.22M $13.64M Hold
Q1 2026 207.45K $5.75M New
Q2 2026 268.01K $9.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 64 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has PFM Health Sciences, LP held ROIV?

PFM Health Sciences, LP has disclosed ROIV holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in ROIV?

As of Q2 2026, PFM Health Sciences, LP holds 268.01K shares of ROIV (ROIVANT SCIENCES LTD), valued at $9.48M, representing 0.83% of its reported portfolio and ranking #46.

Has PFM Health Sciences, LP been buying or selling ROIV?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in ROIV.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.